The journal Cellular & Molecular Immunology published a peer-reviewed study on October 25, 2021, stating, 'COVID-19 vaccines that protect against severe disease and death are considered central to ending the pandemic.' However, the emergence of SARS-CoV-2 coronavirus variants with S protein mutations that confer resistance to neutralization might compromise COVID-19 vaccine efficacy.